Cited 0 times in
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.